Stay updated on PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record now displays 'No longer looking for participants', indicating recruitment has closed. New navigational/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.4%

- Check21 days agoChange DetectedPage revision label updated from v3.5.4 to v3.5.5, reflecting a newer build version. This metadata-level change does not alter the study details, eligibility criteria, or results information presented on the page.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, signaling a newer version of the page. This update reflects a backend or content refresh without altering the displayed study details.SummaryDifference0.0%

- Check57 days agoChange DetectedPage revision tag updated from v3.5.2 to v3.5.3, indicating a newer version of the page. This is a metadata/versioning change and does not alter the study content presented on the page.SummaryDifference0.0%

- Check71 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check85 days agoChange DetectedAdded Marinesco-Sjögren syndrome and a Genetic and Rare Diseases Information Center resources entry to the page.SummaryDifference0.1%

Stay in the know with updates to PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.